About BIOS Health
BIOS Health is a pioneer in AI-driven precision medicine for the nervous system, founded in 2015 by Cambridge University graduates Emil Hewage (computational neuroscientist) and Oliver Armitage (biomechanical engineer). The company has developed proprietary neural interfaces and AI platforms that can read and write the body's neural data in real-time, creating what they call a 'programming language' for the nervous system. BIOS's technology platform transforms neural data into actionable insights to deliver more precise therapies across both bioelectronic and molecular medicine. Their flagship product, BIOS NeuroTune, is an AI co-pilot that personalizes neuromodulation device settings in under ten minutes, reducing the typical 12-month dosing optimization period to minutes. The company serves pharmaceutical companies, neuromodulation device makers, academic researchers, and clinical research organizations. BIOS is the core technology partner for the NIH's SPARC program and the $21M REVEAL study—the world's largest clinical study of human neural data involving eight global clinics including Stanford University, Mayo Clinic, and University of Minnesota. The company envisions neural digital therapeutics as the next generation of precision medicine, similar to how DNA sequencing opened genomics. BIOS operates research facilities in Cambridge, UK and Montreal, Canada, with plans for a commercial precision medicine center in Bakersfield, California.
Mission & Story
Mission
We're on a mission to improve people's quality of life with neural engineering. We envision a future where our Neural Digital Therapy technology is being used to give back control, over our bodies and lives, enabling radically improved, seamlessly experienced healthcare.
Founding Story
Founded in 2015 by Cambridge University graduates Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer. The founders participated in Y Combinator's Winter 2017 batch where they were mentored by Sam Altman.
Clinical Focus
Medical conditions and clinical areas addressed by BIOS Health.
Who It Serves
Milestones & Awards
Recent Milestones
Closed venture funding round June 2023 with Selvedge Venture, XTX Ventures, Real Ventures, Fifty Years, Y Combinator. Selected as core partner for NIH's $21M REVEAL program in 2023. Secured CA$1.8M funding for Canadian AI collaboration on neurocardiology. Plans announced for state-of-the-art precision medicine center in Bakersfield, California.
Awards & Recognition
Named Top Startup by TechCrunch in YC W'17, Top Healthcare Startup in Europe 2019 by Wired Health, EY Startup of the Year 2021, CogX Best Innovation in Personalised Medicine 2022
Key Partnerships
Company Details
- Founded
- 2015
- Headquarters
- Cambridge, England, United Kingdom
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.